Trials / Completed
CompletedNCT01140932
The Electroretinogram in Healthy and Glucose Intolerant Young Men
Electroretinographic Changes in Healthy Young Men Before and After Induction of Glucose Intolerance by Glucocorticoids Treatment, Hyperphagia and Lack of Exercise
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Glostrup University Hospital, Copenhagen · Academic / Other
- Sex
- Male
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The purpose is to investigate the electroretinogram (ERG) in young, healthy men in the normoglycaemic and hyperglycaemic state before and after intervention with corticosteroids treatment, high calorie diet and exercise restraint.
Detailed description
The subjects will be fasting from midnight the day before the experiment. Standard procedures (including pupil dilation, dark adaptation, and local anaesthetics) are carried out to allow the ERG to be obtained. After electrophysiology, the subject will be clamped at a plasma glucose level of 10 mM (\~180 mg/dL) and after a stabilisation period the ERG protocol is repeated. Each subject is examined twice on two different days. The first day the subjects are normoglycaemic in the morning (first examination) and hyperglycaemic (clamped to 10 mM) throughout the second examination. The second day subjects are also normoglycaemic and hyperglycaemic but shows up after 7-12 days of daily intake of prednisolone, high calorie diet, and exercise restraint.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Prednisolone | 12 days of corticosteroids treatment (prednisolone 37,5 mg/day) |
| BEHAVIORAL | Lifestyle change | High calorie diet (130 % of recommended daily energy intake) and relative physical inactivity (no exercise and at least 8 hours of rest/day) |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2010-06-01
- Completion
- 2010-06-01
- First posted
- 2010-06-10
- Last updated
- 2010-12-08
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01140932. Inclusion in this directory is not an endorsement.